Mint Tower Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-27,000
Closed -$2.07M 373
2021
Q4
$2.07M Sell
27,000
-1,700
-6% -$135K 0.27% 79
2021
Q3
$2.16M Hold
28,700
0.27% 68
2021
Q2
$2.23M Buy
28,700
+10,884
+61% +$810K 0.16% 107
2021
Q1
$1.31M Buy
17,816
+1,048
+6% +$77.3K 0.13% 118
2020
Q4
$13K Buy
16,768
+7,336
+78% +$561K ﹤0.01% 127
2020
Q3
$1.63M Sell
9,432
-3,144
-25% -$246K 0.19% 55
2020
Q2
$928K Sell
12,576
-1,153
-8% -$86.8K 0.11% 127
2020
Q1
$1.01M Buy
+13,729
New +$1.08M 0.19% 103
2019
Q2
Sell
-4,716
Closed -$374K 260
2019
Q1
$374K Buy
4,716
+3,967
+530% +$297K 0.04% 129
2018
Q4
$5.46M Buy
+749
New +$52.9K 0.7% 24

Other funds holding MRK

Mint Tower Capital Management's MRK Position: Q1 2021 in Review

Mint Tower Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 1,677 shares — an estimated $124K sold.

Mint Tower Capital Management first reported a position in MRK in Q4 2018 and held it in 5 quarters. The position peaked at $489K in Q4 2018. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Mint Tower Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,677 Merck shares in Q1 2021, an estimated $124K.
  • Mint Tower Capital Management first reported a position in Merck in Q4 2018 and held it in 5 quarters.
  • Mint Tower Capital Management's Merck position peaked at $489K in Q4 2018.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Mint Tower Capital Management's 13F filing for Q1 2021, filed 12 May 2021.